APA

Inoue A., Sugawara S., Maemondo M., Mori Y., Oizumi S., Harada M., Taima K., Morikawa N., Ishida T., Kinoshita I., Watanabe H., Suzuki T., Nakagawa T., Saito R. & Nukiwa T. (20160303). Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702. : Lung cancer (Amsterdam, Netherlands).

Chicago

Inoue Akira, Sugawara Shunichi, Maemondo Makoto, Mori Yoshiaki, Oizumi Satoshi, Harada Masao, Taima Kageaki, Morikawa Naoto, Ishida Takashi, Kinoshita Ichiro, Watanabe Hiroshi, Suzuki Toshiro, Nakagawa Taku, Saito Ryota and Nukiwa Toshihiro. 20160303. Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702. : Lung cancer (Amsterdam, Netherlands).

Harvard

Inoue A., Sugawara S., Maemondo M., Mori Y., Oizumi S., Harada M., Taima K., Morikawa N., Ishida T., Kinoshita I., Watanabe H., Suzuki T., Nakagawa T., Saito R. and Nukiwa T. (20160303). Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702. : Lung cancer (Amsterdam, Netherlands).

MLA

Inoue Akira, Sugawara Shunichi, Maemondo Makoto, Mori Yoshiaki, Oizumi Satoshi, Harada Masao, Taima Kageaki, Morikawa Naoto, Ishida Takashi, Kinoshita Ichiro, Watanabe Hiroshi, Suzuki Toshiro, Nakagawa Taku, Saito Ryota and Nukiwa Toshihiro. Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702. : Lung cancer (Amsterdam, Netherlands). 20160303.